Big Move For Proteon Therapeutics, Inc.
Fri 10 Jan 20 at 05:30 PM
Proteon Therapeutics, Inc. (PRTO:NASDAQ) shot up at $0.84, a gain of 30.5%. On Thu 09 Jan 20, PRTO:NASDAQ hit a New 2-Week High of $0.84. The stock appeared on our News Catalysts scanner on Thu 09 Jan 20 at 07:00 PM in the 'MERGER' category. From Wed 18 Dec 19, the stock recorded 71.43% Up Days and 60.00% Green Days
About Proteon Therapeutics, Inc. (PRTO:NASDAQ)
Proteon Therapeutics Inc is an late-stage biopharmaceutical company engaged in the development of novel pharmaceuticals to address the needs of patients with renal and vascular disease.
Top 10 Gainers:
- CounterPath Corporation (CPAH:NASDAQ), 304.12%
- Origin Agritech Limited (SEED:NASDAQ), 46.92%
- China SXT Pharmaceuticals, Inc. (SXTC:NASDAQ), 42.67%
- Sorrento Therapeutics, Inc. (SRNE:NASDAQ), 39.59%
- Proteon Therapeutics, Inc. (PRTO:NASDAQ), 30.5%
- Lianluo Smart Limited (LLIT:NASDAQ), 28.57%
- Co-Diagnostics, Inc. (CODX:NASDAQ), 28.54%
- Akari Therapeutics, Plc (AKTX:NASDAQ), 25.43%
- Aileron Therapeutics, Inc. (ALRN:NASDAQ), 24.97%
- Nektar Therapeutics (NKTR:NASDAQ), 24.69%